Brief: Coherus Announces U.S. Launch Of Loqtorzi™
Jan 2 (Reuters) - Coherus BioSciences Inc CHRS.O :
* COHERUS ANNOUNCES U.S. LAUNCH OF LOQTORZI™
* LOQTORZI IS NOW AVAILABLE FOR PURCHASE THROUGH SELECT
SPECIALTY
DISTRIBUTORS
* EXPECTS A PRODUCT-SPECIFIC, PERMANENT J-CODE TO BE
ASSIGNED TO
LOQTORZI IN MID-2024
* LOQTORZI IS COMMERCIALLY AVAILABLE FOR PURCHASE THROUGH
SELECT
SPECIALTY DISTRIBUTORS INCLUDING CENCORA , CARDINAL, MCKESSON
Source text for Eikon: ID:nGNX4WQQQf
Further company coverage: CHRS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Coherus Oncology
See all newsBrief: Coherus Oncology Initiates Process To Sell Legacy Biosim Assets
Brief: Coherus Oncology Announces Special Dividend Of Biosimilar Contingent Value Rights
Coherus Oncology Inc reports results for the quarter ended June 30 - Earnings Summary
Coherus Oncology Q2 revenue rises 40% on higher LOQTORZI volume, but slightly falls below estimates
Brief: Coherus Oncology Q2 Net Income USD -20.631 Million